Focal nodular hyperplasia (FNH): A potential cause of false-positive positron emission tomography

Clinical Nuclear Medicine

Volumn 30, Issue 9, 2005, Pages 636-637

  Lopez Aznar D ^a   Ojeda, Reyes ^b   Uruburu Garcia, E ^a   Aparici, F ^a   Abreu Sanchez P ^a   Flores, D ^c   Martinez C ^a   Sopena, R ^a  

^a Hospital 9 de Octubre   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

False positive; FDG PET; Focal nodular hyperplasia

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER FOCAL NODULAR HYPERPLASIA; LIVER METABOLISM; LIVER METASTASIS; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOCAL NODULAR HYPERPLASIA; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 24044460412     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000174209.49753.a5     Document Type: Article

References (10)

1. Swingle CA, Fajman WA, Alazraki N. Early enhancing lesion seen on computed tomography consistent with focal nodular hyperplasia. Clin Nucl Med. 2003;28:134.
2. Ferlicot S, Kobeiter H, Tran van Nhieu J, et al. MRI of atypical focal nodular hyperplasia of the liver: radiology-pathology correlation. AJR Am J Roentgenol. 2004;182:1227.
3. Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT and pathologic analysis. Radiographics. 2004;24:3.
4. Kurtaran A, Becherer A, Pfeffel F, et al. 18F-fluorodeoxiglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver. Liver. 2000;20:487.
5. Ho CL, Yu SC, Yeung DW. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213.
6. Kim J, Ahmad SA, Lowy AM, et al. An algorithm for the accurate identification of benign liver lesions. Am J Surg. 2004;187:274.
7. Mathieu D, Vilgrain V, Mahfouz AE, et al. Benign livers tumors. Magn Reson Imaging Clin N Am. 1997;5:255.
8. Shiomi S, Kurooka H, Iwata Y, et al. Two cases of focal nodular hyperplasia of the liver: value of scintigraphy with Tc-99m GSA and positron emission tomography with FDG. Ann Nucl Med. 1999;13:427.
9. Hain SF, Fogelman I. recent advances in imaging hepatocellular carcinoma: diagnosis, staging and response assessment: functional imaging. Cancer J. 2004;10:121.
10. Iwata Y, Shiomi S, Sasaki, et al. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxiglucose in the diagnosis of liver tumors. Ann Nucl Med. 2000;14:121.